Inventor · disambiguated record
Marc R. Montminy
Also filed as: MONTMINY MARC · MONTMINY MARC R
15 granted patents·4 pending applications·115 citations·filing 1994–2015
92Inventor score
Files withSALK INST FOR BIOLOGICAL STUDI8RES DEV FOUNDATION5MONTMINY MARC1MONTMINY MARC R1RES FOUND DEV1
Top patents by PatentIndex Score
19 records- 0180US7220539B1Protein kinase B/Akt modulators and methods for the use thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2003·Granted May 22, 2007·30 cites·15 claims
- 0278US6646115B1Identification of transcription factor within a cAMP-responsive transcriptional enhancer binding protein (CREB), and uses thereforeSALK INST FOR BIOLOGICAL STUDI·Filed 2000·Granted Nov 11, 2003·3 cites·3 claims
- 0365US6974671B1Methods for indentifying compounds that modulate gluconeogenesis through the binding of CREB to the PGC-1 promoterSALK INST FOR BIOLOGICAL STUDI·Filed 2002·Granted Dec 13, 2005·2 cites·3 claims
- 0464US2004185463A1Methods for treating diabetes mellitusSALK INST FOR BIOLOGICAL STUDI·Filed 2003·Application pending·0 cites
- 0562US5741673ANucleic acid encoding a novel homeobox factor which stimulates insulin expression in pancreatic islet cellsRES DEV FOUNDATION·Filed 1996·Granted Apr 21, 1998·23 cites·9 claims
- 0661US6063583ACyclic amp response element binding protein (CREB)-CREB binding protein complexSALK INST FOR BIOLOGICAL STUDI·Filed 1997·Granted May 16, 2000·16 cites·6 claims
- 0759US8389207B2Methods for identifying candidate fat-mobilizing agentsMONTMINY MARC·Filed 2007·Granted Mar 5, 2013·1 cites·17 claims
- 0856US8192945B2Method for screening compounds to determine those which enhance islet cell activity and/or survival and uses thereforMONTMINY MARC R·Filed 2008·Granted Jun 5, 2012·0 cites·11 claims
- 0954US7485434B2Method for screening compounds for those that modulate transducers of regulated CREB activitySALK INST FOR BIOLOGICAL STUDI·Filed 2006·Granted Feb 3, 2009·0 cites·4 claims
- 1052US5849493AScreening assay for compounds stimulating somatostatin transcription factor -1 binding to an STF-1 binding siteRES DEV FOUNDATION·Filed 1996·Granted Dec 15, 1998·18 cites·6 claims
- 1145US9693994B2Class IIa HDAC inhibitors for the treatment of infectionRES DEV FOUNDATION·Filed 2015·Granted Jul 4, 2017·0 cites·13 claims
- 1243US5955579AIslet-specific homeoprotein and transcriptional regulator of insulin gene expression, HOXB13STRANG CANCER PREVENTION CENTE·Filed 1995·Granted Sep 21, 1999·10 cites·10 claims
- 1343US5750336AAssays for the identification of compounds which inhibit activation of cAMP and mitogen responsive genesSALK INST FOR BIOLOGICAL STUDI·Filed 1994·Granted May 12, 1998·4 cites·20 claims
- 1440US10258639B2Methods for treating insulin resistance and for sensitizing patients to GLP1 agonist therapyRES FOUND DEV·Filed 2015·Granted Apr 16, 2019·0 cites·15 claims
- 1539US5814459APhosphospecific transcription factor antibodiesSALK INST FOR BIOLOGICAL STUDI·Filed 1995·Granted Sep 29, 1998·5 cites·14 claims
- 1639US2013143800A1Combination therapies to treat diabetesRES DEV FOUNDATION·Filed 2012·Application pending·0 cites
- 1738US2003086928A1Compositions associated with complex formation and methods of use thereofFiled 2002·Application pending·0 cites
- 1837US5969210AMethods for the characterization of compounds which stimulate STF-1 expression in pancreatic islet cellsRES DEV FOUNDATION·Filed 1997·Granted Oct 19, 1999·3 cites·9 claims
- 1932US2014314788A1Modulation of histone deacetylases for the treatment of metabolic disease, methods and compositions related theretoSHAW REUBEN J·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc R. Montminy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →